Sebastian Mannweiler
Overview
Explore the profile of Sebastian Mannweiler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
817
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Maisel F, Smolle M, Mollnar S, Riedl J, Barth D, Seles M, et al.
Clin Genitourin Cancer
. 2022 Apr;
20(4):344-353.
PMID: 35443915
Introduction: To quantify the magnitude of benefit of metastasectomy as compared to medical treatment alone in patients with metastatic renal cell carcinoma (mRCC). Patients And Methods: We therefore conducted a...
12.
Barth D, Sareban N, Lindner A, Daller L, Matzhold E, Hutterer G, et al.
Urol Oncol
. 2021 Jul;
39(10):736.e9-736.e16.
PMID: 34247906
Background: The ABO blood group system has been previously discussed as a risk factor to develop, as well as a prognostic factor in non-metastatic renal cell carcinoma (RCC). Controversial findings...
13.
Sylvester R, Rodriguez O, Hernandez V, Turturica D, Bauerova L, Bruins H, et al.
Eur Urol
. 2021 Jan;
79(4):480-488.
PMID: 33419683
Background: The European Association of Urology (EAU) prognostic factor risk groups for non-muscle-invasive bladder cancer (NMIBC) are used to provide recommendations for patient treatment after transurethral resection of bladder tumor...
14.
Moritz J, Bauernhofer T, Mannweiler S, Langsenlehner T, Pummer K, Dandachi N, et al.
In Vivo
. 2020 Nov;
34(6):3631-3638.
PMID: 33144478
Background/aim: Carboplatin-containing treatment regimens demonstrate moderate efficacy in metastatic castration-resistant prostate cancer (mCRPC). In this study, we retrospectively analyzed the efficacy of carboplatin in relation to blood-based parameters. Patients And...
15.
Riegler M, Mannweiler S, Sturm A, Donnerer A, Darok M, Kopera D
Dermatol Ther
. 2020 Jul;
33(6):e14037.
PMID: 32691482
No abstract available.
16.
Hentschel A, van Rhijn B, Brundl J, Comperat E, Plass K, Rodriguez O, et al.
Urol Oncol
. 2019 Nov;
38(5):440-448.
PMID: 31704141
Background: Papillary urothelial neoplasm of low malignant potential (PUN-LMP) was introduced as a noninvasive, noncancerous lesion and a separate grade category in 1998. Subsequently, PUN-LMP was reconfirmed by World Health...
17.
Mischinger J, Frohlich E, Mannweiler S, Meindl C, Absenger-Novak M, Hutterer G, et al.
Cent European J Urol
. 2019 Apr;
72(1):23-31.
PMID: 31011436
Introduction: We compared the potential prognostic impact of B7-H1 and B7-H3 glycoprotein expressions with the Mayo Clinic Stage, Size, Grade, and Necrosis (SSIGN) score in metastatic clear cell renal cell...
18.
Hutterer G, Sobolev N, Ehrlich G, Gutschi T, Stojakovic T, Mannweiler S, et al.
J Clin Pathol
. 2015 Feb;
68(5):351-5.
PMID: 25661796
Aims: To investigate the potential prognostic impact of the lymphocyte-monocyte ratio (LMR) in a large European cohort of patients with localised upper urinary tract urothelial carcinoma (UTUC). The LMR as...
19.
Pichler M, Dalpiaz O, Ehrlich G, Stojakovic T, Martin Hernandez J, Mannweiler S, et al.
J Urol
. 2014 Feb;
191(4):920-5.
PMID: 24513163
Purpose: Fibrinogen is thought to have a potentially significant role in the progression and metastatic spread of different human cancers. A recent study from Asia indicated that elevated preoperative plasma...
20.
Dalpiaz O, Ehrlich G, Mannweiler S, Martin Hernandez J, Gerger A, Stojakovic T, et al.
BJU Int
. 2013 Sep;
114(3):334-9.
PMID: 24053693
Objective: To investigate the potential prognostic significance of the neutrophil-lymphocyte ratio (NLR) in a large European cohort of patients with upper urinary tract urothelial cell carcinoma (UUT-UCC). Patients And Methods:...